Healthy volunteers 247031 Part C
Study Dates:
Screening will take place throughout 2021 - please call 01895 614 888 for the latest screening days and times.
Trial Number
247031
Group
● Healthy Volunteer
● Non-Childbearing Females
Compensation
Up to: $4,092
Gender
Male, Female
Age
18-55
Additional Information
For
the Treatment Period, you will be admitted to the Unit on Day ‑1 (the day
before the first dosing) or Day-2 if admitted to a cohort where a CSF sample is required. You will then be required to stay in
the Unit for 18 days and 17 nights and 1
follow-up phone call (19 days and 18 nights if CSF sample Cohort).
We will compensate you for your time and inconvenience (which includes travel expenses and compensation for any lifestyle restrictions) to the sum of £4,092.50
The sum of (£4,852.50) for CSF cohorts.
Details
The Study drug is being developed to treat patients who suffer from a disease known as Multiple System Atrophy (A fatal neuro-degenerative disorder where brain cells progressively die leading to loss of many body functions, including breathing and eating.